Bio-Rad Laboratories Inc (BIO)
Financial leverage ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total assets | US$ in thousands | 9,364,100 | 10,603,500 | 9,688,450 | 12,609,900 | 12,299,100 | 11,895,900 | 11,978,200 | 13,667,400 | 13,501,700 | 12,058,500 | 12,682,100 | 14,373,700 | 17,775,800 | 19,953,400 | 15,117,600 | 13,933,200 | 12,972,600 | 12,020,900 | 10,097,300 | 8,684,360 |
Total stockholders’ equity | US$ in thousands | 6,569,300 | 7,487,860 | 6,778,790 | 9,051,130 | 8,741,130 | 8,416,200 | 8,446,890 | 9,763,720 | 9,615,250 | 8,453,600 | 8,922,600 | 10,182,900 | 13,667,100 | 15,332,400 | 11,594,900 | 10,609,100 | 9,879,940 | 8,825,140 | 7,353,400 | 6,293,080 |
Financial leverage ratio | 1.43 | 1.42 | 1.43 | 1.39 | 1.41 | 1.41 | 1.42 | 1.40 | 1.40 | 1.43 | 1.42 | 1.41 | 1.30 | 1.30 | 1.30 | 1.31 | 1.31 | 1.36 | 1.37 | 1.38 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $9,364,100K ÷ $6,569,300K
= 1.43
The financial leverage ratio for Bio-Rad Laboratories Inc has exhibited a relatively stable trend over the period from March 31, 2020, to December 31, 2024, fluctuating between 1.30 and 1.43. This ratio indicates the level of debt financing used by the company compared to its equity. A higher financial leverage ratio suggests that a larger proportion of the company's assets are funded by debt, indicating higher financial risk.
Bio-Rad's financial leverage ratio showed a slight decline from 1.38 on March 31, 2020, to 1.31 on December 31, 2020. However, the ratio remained relatively consistent around 1.30 from March 31, 2021, to December 31, 2023, signaling a stable debt-to-equity mix. Subsequently, the ratio experienced a slight increase to 1.43 on June 30, 2024, followed by some fluctuations around this level.
Overall, the financial leverage ratio suggests that Bio-Rad Laboratories Inc has maintained a relatively balanced mix of debt and equity in its capital structure during the analyzed period, with a slight uptrend in recent periods. It is important for investors and stakeholders to monitor this ratio to assess the company's ability to meet its financial obligations and manage potential risks associated with leverage.
Peer comparison
Dec 31, 2024